Acadia Pharmaceuticals Inc.
4.32xPrice / tangible book
Market cap
$4.83B
Tangible equity
$1.12B
Price / tangible book
4.32x
Price / book
3.94x
Return on equity
31.9%
Return on assets
25.0%
Efficiency ratio
—
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at HBAN's multiple
$28.210.6% above market
2.30 ACAD EPS (TTM)×12.27x HBAN P/E=$28.21
Market $28.04Implied $28.21
HBAN · current priceP/E 12.27x
$17.05Latest market snapshot
Implied fair value · at ACAD's multiple
$16.950.6% below market
1.39 HBAN EPS (TTM)×12.19x ACAD P/E=$16.95
Market $17.05Implied $16.95